Prevalence of polymorphisms in thiopurine metabolism and association with adverse outcomes: a South Asian region-specific systematic review and meta-analysis-Reference-Cited by-同舟云学术

Prevalence of polymorphisms in thiopurine metabolism and association with adverse outcomes: a South Asian region-specific systematic review and meta-analysis

Published:2021-03-15 Issue:4 Volume:14 Page:491-501
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Jena Anuraag¹^ORCID,Jha Daya Krishna¹,Kumar-M Praveen²^ORCID,Kasudhan Kripa Shanker²,Kumar Ankit²,Sarwal Dhruv³^ORCID,Mishra Shubhra¹^ORCID,Singh Anupam Kumar¹^ORCID,Bhatia Prateek⁴,Patil Amol²^ORCID,Sharma Vishal¹^ORCID

Affiliation:

1. Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

2. Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

3. Government Medical College and hospital- Sector 32, Ex-intern, Chandigarh, India

4. Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2021.1900729

Reference64 articles.

1. Pharmacogenetic testing: current evidence of clinical utility

2. Very important pharmacogene summary: thiopurine S-methyltransferase

3. Dean L, Kane M. Mercaptopurine therapy and TPMT and NUDT15 genotype. Medical Genetics Summaries. Bethesda (MD): National Center for Biotechnology Information (US); (2012).

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of TPMT and NUDT15 Genetic Polymorphisms on Mercaptopurine Pharmacokinetics in Healthy Volunteers;Genetic Testing and Molecular Biomarkers;2024-08-01

2. Innovating Thiopurine Therapeutic Drug Monitoring: A Systematic Review and Meta-Analysis on DNA-Thioguanine Nucleotides (DNA-TG) as an Inclusive Biomarker in Thiopurine Therapy;Clinical Pharmacokinetics;2024-07-20

3. Pharmacogenomic Assessment of Genes Implicated in Thiopurine Metabolism and Toxicity in a UK Cohort of Pediatric Patients With Inflammatory Bowel Disease;Inflammatory Bowel Diseases;2024-07-16

4. Uphill battle: Innovation of thiopurine therapy in global inflammatory bowel disease care;Indian Journal of Gastroenterology;2024-02

5. Population-Specific Distribution of TPMT Deficiency Variants and Ancestry Proportions in Ecuadorian Ethnic Groups: Towards Personalized Medicine;Therapeutics and Clinical Risk Management;2023-11